Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
36.21
+0.33 (0.92%)
At close: Nov 18, 2025, 4:00 PM EST
36.29
+0.08 (0.22%)
After-hours: Nov 18, 2025, 4:08 PM EST
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.95 billion as of November 18, 2025. Its market cap has increased by 131.08% in one year.
Market Cap
1.95B
Enterprise Value
1.63B
1-Year Change
131.08%
Ranking
Category
Stock Price
$36.21
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.95B, an increase of 188.64%. That is a compound annual growth rate of 145.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 1.93B | 462.72% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |